Use access key #2 to skip to page content.
$12.72 -1.25 (-8.95%)
10/15/2008 4:00 PM

ISIS Pharmaceuticals, Inc. (ISIS)

CAPS Rating:
****

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

View All Commentary (ISIS)

Recs

0

Avatar RoRo4 (53.78) Submitted: 7/16/08 11:17 AM : Outperform Start Price: $15.06 ISIS Score: 10.93

The analysts know more than you do. This is a winner

Report this Post Replies: 0 | Reply

Featured Broker Partners

Sponsored Links